3.59
Precedente Chiudi:
$3.77
Aprire:
$3.74
Volume 24 ore:
220.65K
Relative Volume:
0.12
Capitalizzazione di mercato:
$87.69M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-24.10%
1M Prestazione:
+21.69%
6M Prestazione:
+47.13%
1 anno Prestazione:
-67.92%
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
Nome
Artiva Biotherapeutics Inc
Settore
Industria
Telefono
(858) 267-4467
Indirizzo
5505 MOREHOUSE DRIVE, SAN DIEGO
Confronta ARTV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ARTV
Artiva Biotherapeutics Inc
|
3.59 | 92.09M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-11 | Ripresa | H.C. Wainwright | Buy |
| 2024-12-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-08-13 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-13 | Iniziato | Jefferies | Buy |
| 2024-08-13 | Iniziato | Needham | Buy |
| 2024-08-13 | Iniziato | TD Cowen | Buy |
| 2024-08-13 | Iniziato | Wedbush | Outperform |
Mostra tutto
Artiva Biotherapeutics Inc Borsa (ARTV) Ultime notizie
What risks investors should watch in Artiva Biotherapeutics Inc. stockMarket Performance Report & Daily Entry Point Alerts - newser.com
Is Artiva Biotherapeutics Inc. stock attractive for retirement portfoliosInflation Watch & Weekly Stock Breakout Alerts - newser.com
Is Artiva Biotherapeutics Inc. stock supported by strong cash flows2025 Breakouts & Breakdowns & Safe Entry Zone Identification - newser.com
Artiva Biotherapeutics Inc. stock daily chart insightsEarnings Summary Report & Free AI Powered Buy and Sell Recommendations - newser.com
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK® - The Manila Times
Artiva Biotherapeutics to Host Webcast on Initial Safety and Translational Data for AlloNK in Autoimmune Disease Treatment - Quiver Quantitative
Can Artiva Biotherapeutics Inc. stock resist sector downturnsPortfolio Risk Report & AI Driven Stock Movement Reports - newser.com
Relative strength of Artiva Biotherapeutics Inc. in sector analysis2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Advanced analytics toolkit walkthrough for Artiva Biotherapeutics Inc.2025 Stock Rankings & Weekly Breakout Stock Alerts - newser.com
Why Artiva Biotherapeutics Inc. stock could rally in 2025Quarterly Portfolio Review & Verified Momentum Watchlists - newser.com
Why Artiva Biotherapeutics Inc. stock is popular among millennialsWeekly Market Summary & AI Enhanced Trading Signals - newser.com
How resilient is Artiva Biotherapeutics Inc. stock in market downturnsEarnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Published on: 2025-11-03 03:05:55 - newser.com
Will Artiva Biotherapeutics Inc. stock beat EPS estimatesPortfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
Identifying reversal signals in Artiva Biotherapeutics Inc.July 2025 PreEarnings & Fast Gaining Stock Reports - newser.com
How to escape a deep drawdown in Artiva Biotherapeutics Inc.Oil Prices & Fast Entry and Exit Trade Plans - newser.com
Artiva Biotherapeutics Inc. stock volume spike explained2025 Top Decliners & Free Verified High Yield Trade Plans - newser.com
Published on: 2025-11-02 01:36:46 - newser.com
Published on: 2025-11-01 12:39:19 - newser.com
Published on: 2025-11-01 06:37:19 - newser.com
Best Small Cap Stocks To ConsiderOctober 19th - MarketBeat
Artiva Biotherapeutics (NASDAQ:ARTV) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Why analysts remain bullish on Artiva Biotherapeutics Inc. stockBull Run & Free Weekly Watchlist of Top Performers - newser.com
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November - GlobeNewswire
Artiva Bio Soaring on Focus Shift from Oncology to Autoimmune Disease - San Diego Business Journal
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Artiva Biotherapeutics Inc Azioni (ARTV) Dati Finanziari
Non sono disponibili dati finanziari per Artiva Biotherapeutics Inc (ARTV). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):